AI, GLP-1s Among Topics to Be Discussed During ASPC Annual Meeting

The American Society for Preventive Cardiology (ASPC) 2025 Congress on Cardiovascular Disease (CVD) Prevention, to be held in Boston from August 1 to August 3, 2025, is set to include breaking information on the prevention of CVD through traditional and new methods. Specifically, artificial intelligence (AI) and glucagon-like peptide-1 (GLP-1) receptor agonists will be highlighted as potential tools for cardiologists to use in practice.¹

This year marks the 40th anniversary of the annual meeting from ASPC, where the theme will be “inclusiveness and the care of one and all at risk for cardiovascular disease.”² This theme is demonstrated through the sessions held throughout the weekend, focusing on discussions and debates in cardiology, how prospective cohorts have informed the prevention of CVD, and expanding the scope of heart failure and atrial fibrillation, among other sessions offered. According to David J. Maron, MD, FASPC, the theme also extends to the participants of the conference, with doctors at all stages of their careers set to attend. The conference is set to make good on that promise, as early-career cardiologists will be able to present their research during the “Early Career Research Presentations” session to be held on August 2, allowing for those starting in the field to have guaranteed time to talk about their research.¹

ASPC 2025 Congress on CVD Prevention is set to include multiple sessions across a 3-day span, including sessions on AI and GLP-1s | Image credit: ASPC

AI and GLP-1s will take center stage during the congress, with sessions entitled “Artificial Intelligence and Technology in the Practice of Preventive Cardiology” and “Exploring the Impact of GLP-1 Receptor Agonists” making up the fifth and twelfth sessions offered over the weekend. The sessions will cover the ways that AI and GLP-1s can be used by cardiologists to help in preventing CVD and continuing to prevent CVD in the future.

Debates will also be must-see events, with “Discussions and Debates in Preventive Cardiology” having 2 rounds spread out between Friday and Saturday. These debates will feature seasoned cardiologists taking up either the pro or con side and debating about the use of different tools in preventing CVD. Both sessions will feature 2 hours of debates and discussions on these topics, which can help to clarify each side of each topic.

Posters will also be highlighted during the conference, with oral abstracts presented on both nights of the conference. The hour-long presentations are set to present 19 different abstracts across the 2 nights, focusing on research on pregnancy in CVD, use of AI as a prediction model, and lipoprotein(a) in CVD. These oral abstract presentations will be in conjunction with more than 150 poster abstracts set to be presented during the meeting.

ASPC is set to have something for everyone interested in preventing CVD, with sessions to satisfy all cardiologists looking to learn this weekend. As all attendees prepare to take part in the conference, Moran emphasizes that there is plenty to be excited about.

“I have to say that I'm really looking forward to the whole thing. We have a fantastic faculty, and they're going to be presenting and debating on a range of topics that I think are of pressing interest…” said Maron. “There are going to be some great debates. I think that there's a lot to be looking forward to.”²

References

1. ASPC 2025 congress on CVD prevention. ASPC. Accessed July 28, 2025. https://www.aspconline.org/events/aspc-2025-congress-on-cvd-prevention#agenda

2. Shaw ML, Maron DJ. Debates, deep dives, and prevention strategies: what to expect at ASPC 2025 with David J. Maron, MD, FASPC. AJMC®. July 28, 2025. Accessed July 28, 2025. https://www.ajmc.com/view/debates-deep-dives-and-prevention-strategies-what-to-expect-at-aspc-2025-with-david-j-maron-md-faspc